MMIT and MDLinx, a Part of M3 Group, Announce Integration to Deliver Market Access Information Directly to Healthcare Providers

  MMIT and MDLinx, a Part of M3 Group, Announce Integration to Deliver Market
  Access Information Directly to Healthcare Providers

Business Wire

YARDLEY, Pa. & WASHINGTON -- September 24, 2013

MMIT ( provides trusted formulary data and software solutions
to payers, pharmaceutical manufacturers and physicians to help them make
informed managed care decisions. Every day MDLinx ( educates
and updates nearly half a million healthcare professionals with trusted
clinical and medical news content. Together, the combination delivers MMIT’s
high integrity information directly to hundreds of thousands of physicians via
MDLinx – the #1 ranked specialty website.

“Pharmaceutical companies will now have a way to leverage their contracting
wins and advantaged formulary status through a doctor trusted network,” said
Jeff Steinberg, CEO of MMIT. “Our partnership with MDLinx is a valuable
extension of MMIT’s existing pull through platform, one which will provide
clients geographically targeted access to the specialists that they want to
reach. Most importantly, the tight bundling of online promotional messaging,
rebating, and field sales force reinforcement will enhance the ROI of our
client’s largest marketing investments.”

“We are excited to join with MMIT in the launch of an innovative product that
builds upon the broad reach of MDLinx. MMIT’s pharmacist validated market
access data nicely complement our historic commitment of providing valuable,
informative, practical content to healthcare professionals,” comments Aki
Tomaru, CEO of M3 USA.

With the proliferation of specialty drugs, reaching specialists with accurate,
easily understood information has never been more critical. Pharmaceutical
brands can now quickly communicate market access position to targeted groups
of physicians and scale this messaging down to a local level. Formally
launching at NASP’s Specialty Pharmacy Strategic Business Exchange in October,
this joint product is immediately available to a select group of brand teams.
For more information, please contact Dan O’Brien at or

About M3 USA

The M3 Group operates in the US, Asia, and Europe with over 1.2 million
physician members globally via its physician websites such as,,, and MDLinx is an
award-winning, practical medical information tool used by busy physicians and
healthcare professionals to stay up to date with the latest research in the
medical field. M3 Inc. is a publicly traded company on the Tokyo Stock
Exchange (jp:2413) with subsidiaries in major markets including USA, UK,
Japan, S. Korea, and China. M3 Group provides services to healthcare and the
life science industry. In addition to market research, these services include
medical education, ethical drug promotion, clinical development, job
recruitment, and clinic appointment services. M3 has offices in Tokyo,
Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.

About MMIT

MMIT provides complete and accurate market access information to the rapidly
changing healthcare market. Payers, pharmaceutical manufacturers, healthcare
providers and pharmacies use MMIT’s information in important business and
decision-making processes to gain the key insights needed to navigate the
market’s reforms. Our solutions are used from P&T through to point of care –
ensuring consistent, informed managed care decisions across the healthcare
spectrum. MMIT is located in Yardley, PA.


Dan O’Brien, 267-753-6800
Richard Britton, 202-293-2288 x9.221
Press spacebar to pause and continue. Press esc to stop.